Association of serum fibroblast growth factor 19 levels with arteriosclerosis parameters assessed by arterial stiffness and atherogenic index of plasma in patients with type 2 diabetes

The role of serum fibroblast growth factor 19 (FGF19) in arteriosclerosis is not well known. In the present study, we aimed to explore whether serum FGF19 levels were related to arteriosclerosis parameters, in...

Source: Diabetology and Metabolic Syndrome - May 20, 2020 Category: Endocrinology Authors: Wang-shu Liu, Meng-jie Tang, Tian-li Xu, Jian-bin Su, Xue-qin Wang, Feng Xu, Dong-mei Zhang, Qing Zhu, Jie Cao and Hong Wang Tags: Research Source Type: research